Disparate Effects of Metformin on Mycobacterium tuberculosis Infection in Diabetic and Nondiabetic Mice

Title
Disparate Effects of Metformin on Mycobacterium tuberculosis Infection in Diabetic and Nondiabetic Mice
Publication Date
2020-12-16
Author(s)
Sathkumara, Harindra D
Hansen, Karyna
Miranda-Hernandez, Socorro
Govan, Brenda
Rush, Catherine M
Henning, Lars
Ketheesan, Natkunam
( author )
OrcID: https://orcid.org/0000-0002-4870-706X
Email: nkethees@une.edu.au
UNE Id une-id:nkethees
Kupz, Andreas
Type of document
Journal Article
Language
en
Entity Type
Publication
Publisher
American Society for Microbiology
Place of publication
United States of America
DOI
10.1128/AAC.01422-20
UNE publication id
une:1959.11/46928
Abstract
Comorbid type 2 diabetes poses a great challenge to the global control of tuberculosis. Here, we assessed the efficacy of metformin (MET), an antidiabetic drug, in mice infected with a very low dose of Mycobacterium tuberculosis. In contrast to diabetic mice, infected nondiabetic mice that received the same therapeutic concentration of MET presented with significantly higher disease burden. This warrants further studies to investigate the disparate efficacy of MET against tuberculosis in diabetic and nondiabetic individuals.
Link
Citation
Antimicrobial Agents and Chemotherapy, 65(1), p. 1-5
ISSN
1098-6596
0066-4804
Pubmed ID
33046495
Start page
1
End page
5

Files:

NameSizeformatDescriptionLink